<div class="container">

<table style="width: 100%;"><tr>
<td>cml</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2> Data of Patients With Chronic Myeloid Leukaemia </h2>

<h3>Description</h3>

<p>data of patients with chronic myeloid leukaemia
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(cml)</code></pre>


<h3>Format</h3>

<p>A data frame with 104 observations on the following 10 variables.
</p>

<dl>
<dt><code>CCgR01</code></dt>
<dd>
<p> time from therapy initiation to achievement of the first disease remission </p>
</dd>
<dt><code>loss_CCgR01</code></dt>
<dd>
<p> time from therapy initiation to loss of the first disease remission </p>
</dd>
<dt><code>CCgR02</code></dt>
<dd>
<p> time from therapy initiation to achievement of the second disease remission </p>
</dd>
<dt><code>loss_CCgR02</code></dt>
<dd>
<p> time from therapy initiation to loss of the second disease remission </p>
</dd> 
<dt><code>CCgR03</code></dt>
<dd>
<p> time from therapy initiation to achievement of the third disease remission </p>
</dd>
<dt><code>follow.up</code></dt>
<dd>
<p> follow-up time (time from therapy initiation to death or to the date of last contact with a patient) </p>
</dd>
<dt><code>death</code></dt>
<dd>
<p> censoring indicator (1..patient died, 0..patient is censored) </p>
</dd>
<dt><code>sokal</code></dt>
<dd>
<p> Sokal score (1..low-risk, 2..intermediate-risk, 3..high-risk) </p>
</dd>
<dt><code>euro</code></dt>
<dd>
<p> Euro score (1..low-risk, 2..intermediate-risk, 3..high-risk) </p>
</dd>
<dt><code>eutos</code></dt>
<dd>
<p> EUTOS score (0..low-risk, 1..high-risk) </p>
</dd>
</dl>
<h3>Source</h3>

<p> population-based, observational study, INFINITY (<a href="https://www.leukemia-cell.org/index-en.php?pg=infinity--project-information">https://www.leukemia-cell.org/index-en.php?pg=infinityâ€“project-information</a>) </p>


<h3>References</h3>

 
<p>Pavlik T., Janousova E., Pospisil Z., et al. (2011). Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. <em>BMC Med Res Methodol</em> <b>11</b>:140.
</p>


<h3>Examples</h3>

<pre><code class="language-R">data(cml)
str(cml)
</code></pre>


</div>